Medicinal Cannabis Matters: Friday Roundup - 27 March 2026

A Patient Perspective on Finding Relief From Chronic Pain

A recent story from Portsmouth shares the experience of a patient living with chronic pain who describes medicinal cannabis as an “eye-opener” after years of limited success with conventional treatments.

After being prescribed through a specialist clinic, the patient reports improved symptom management and a noticeable change in day-to-day quality of life. For many individuals living with persistent pain, this kind of outcome reflects the value of having access to alternative, clinically supervised treatment options when standard approaches have not provided sufficient relief.

Stories like this continue to highlight the importance of patient-centred care and the role medicinal cannabis can play within it.

New Data Shows Positive Outcomes Between Anxiety and Medicinal Cannabis

New findings reported by Leafie suggest that 94% of patients using medicinal cannabis for anxiety experienced some level of symptom relief. This adds to a growing body of real-world data supporting the use of medicinal cannabis in carefully selected patients under clinical supervision.

Anxiety can have a significant impact on daily life, affecting sleep, focus and overall wellbeing. While medicinal cannabis is not suitable for everyone, these results reinforce its potential as part of a broader, personalised treatment plan.

Balancing Regulation and Access in Jersey

In Jersey, ongoing discussions around planning and regulation are shaping how medicinal cannabis is integrated into the local community. A recent article explores how policymakers are working to balance public concerns with the need to support a regulated and accessible cannabis sector.

For patients, clear and well-structured regulation is essential. It ensures that access to treatment is safe and supported by appropriate clinical oversight. As frameworks continue to develop, local decisions will play an important role in how easily patients can access care and how confidently communities engage with medicinal cannabis services.

India Invests in Cannabis Research

Internationally, India has issued its first government-backed cannabis research grant, marking a significant step towards expanding scientific understanding of medicinal cannabis.

As reported by Business of Cannabis, this initiative could help open up the market while strengthening the global evidence base. Investment in research is key to advancing clinical knowledge, improving treatment protocols and supporting the development of robust regulatory systems.

Although healthcare systems vary, global progress contributes to a shared understanding that ultimately benefits patients everywhere.

This week’s stories reflect a sector that is continuing to mature. Patient experiences, emerging data and regulatory developments are all contributing to a more informed and balanced conversation around medicinal cannabis.

For patients, this means greater clarity and safer access to exploring treatment options that may improve quality of life.
If you are considering whether medicinal cannabis may be suitable for your condition, you can check your eligibility online in just two minutes. The process is confidential and provides a straightforward starting point before speaking with a specialist clinician.

Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.